Today, Sunday, NCB Capital, in its capacity as the underwriting manager for the initial public offering of Nahdi Medical Company, announced the completion of the offering process for the individuals category and the allocation of a minimum of 3 shares to each individual subscriber included in the subscription application.
The company said that the remaining shares will be allocated on a pro-rata basis based on the volume of each subscriber’s request to the total remaining shares required to be subscribed, with an allocation rate of 1.243% on a pro-rata basis.
The company offered 39,000,000 shares, representing 30% of the company’s capital, 90% of which were allocated to the participating parties (institutions) and 10% to individuals.
The individuals’ subscription period began on Sunday, March 13, 2022, and ended on Tuesday, March 15, 2022, by subscribing to the entire shares allocated to this segment, amounting to 3,900,000 shares, representing 10% of the total offered shares, at a price of 131 riyals per share, through the receiving entities. .
The company indicated that the number of individual participants reached 1,099,863 to subscribe to 3,900,000 shares at a price of 131 riyals per share.
She explained that the subscription of individuals was covered 13 times, with a total request of 6.76 billion riyals.